Effects of apomorphine and haloperidol on plasma cortisol levels in conscious dogs. 1981

K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan

Cortisol levels were measured in peripheral plasma of conscious dogs after i.v. administration of apomorphine, a dopaminergic agonist, haloperidol, a dopaminergic antagonist, or apomorphine in combination with haloperidol. Apomorphine in a dose of 0.001 and 0.005 mg/kg did not cause any release of cortisol whereas 0.01 and 0.05 mg/kg caused a dose dependent and peakshaped increase of plasma cortisol levels from 20 to 30 and from 20 to 60 ng/ml respectively. Basal levels were reached again within 1 h. Haloperidol (0.1 mg/kg), when given alone, induced a continuous rise of plasma cortisol levels. After 60 min the levels were approximately 80 ng/ml and still tended to rise. If apomorphine (0.01 mg/kg) was given 30 min after the injection of haloperidol (0.5 mg/kg) no further effect of the apomorphine injections was observed. We therefore speculate that apomorphine activates central dopaminergic receptors which cause a release of ACTH from the pituitary into the circulation, which in turn stimulates the release of cortisol from the adrenals. The fact that not only apomorphine but also haloperidol stimulated cortisol release suggests a complex role or dopamine transmission involving different dopaminergic pathways as well as different dopamine receptors. It is also possible that injection of haloperidol induces a stress reaction in the dogs, which causes a release of cortisol from the adrenals.

UI MeSH Term Description Entries
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm

Related Publications

K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
April 1985, Journal of clinical psychopharmacology,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
March 1988, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
January 1983, Voprosy onkologii,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
December 1992, Metabolism: clinical and experimental,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
February 1995, The American journal of physiology,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
June 1989, International journal of biometeorology,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
October 1989, Pharmacology, biochemistry, and behavior,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
April 1969, The American journal of physiology,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
October 1982, Biochemical pharmacology,
K Uvnäs-Wallensten, and M Goiny, and M A Oriowo, and S Cekan
August 1986, The Journal of physiology,
Copied contents to your clipboard!